Related Articles
Prognostic value of serum CEA and CA19‑9 levels in pancreatic ductal adenocarcinoma
Serum miR‑210‑3p can be used to differentiate between patients with pancreatic ductal adenocarcinoma and chronic pancreatitis
Combined detection of serum UL16‑binding protein 2 and macrophage inhibitory cytokine‑1 improves early diagnosis and prognostic prediction of pancreatic cancer
Carbohydrate antigen 19‑9 as a prognostic biomarker in pancreatic neuroendocrine tumors
Successful treatment of a locally advanced unresectable pancreatic cancer patient with interstitial pneumonitis by conversion surgery following gemcitabine plus nab‑paclitaxel chemotherapy: A case report